Familial rhabdoid tumour 'avant la lettre'—from pathology review to exome sequencing and back again

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pathology

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.4225PMID 23775540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• Targeted Next‐Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics

  2013cited by this paper
• Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient

  2013cited by this paper
• Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer.

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

  2012cited by this paper
• Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer

  2012cited by this paper
• Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.

  2012cited by this paper
• Dissecting the genomic complexity underlying medulloblastoma

  2012cited by this paper
• Targeted therapies: how personal should we go?

  2012cited by this paper
• A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.

  2012cited by this paper
• Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Epigenetic regulation of human embryonic stem cells

  2012cited by this paper
• Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

  2012cited by this paper
• Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.

  2011cited by this paper
• SWI/SNF nucleosome remodellers and cancer

  2011cited by this paper
• Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

  2011cited by this paper
• Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas

  2011cited by this paper
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors

  2011cited by this paper
• Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer

  2011cited by this paper
• Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

  2011cited by this paper
• Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• The role of SMARCB1/INI1 in the development of rhabdoid tumors

  2009cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay.

  2008cited by this paper
• Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature.

  2007cited by this paper
• Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers

  2007cited by this paper
• Genetic and epigenetic alterations of BRG1 promote oral cancer development.

  2005cited by this paper
• INI1 Protein Expression Distinguishes Atypical Teratoid/Rhabdoid Tumor from Choroid Plexus Carcinoma

  2005cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies

  2001cited by this paper
• BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.

  2000cited by this paper
• BRG 1 , a Component of the SWI-SNF Complex , Is Mutated in Multiple Human Tumor Cell Lines

  2000cited by this paper
• Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.

  2000cited by this paper
• Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.

  1999cited by this paper
• Immature teratomas of different origin carried by a pregnant mother and her fetus.

  1993cited by this paper
• Germ cell tumors of the ovary.

  1987cited by this paper
• A greatly simplified method of establishing B-lymphoblastoid cell lines.

  1978cited by this paper

• Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant

  2025cites this paper
• Neonatal rhabdoid tumor presenting as feeding intolerance and vomiting: A case report

  2024cites this paper
• SMARCA4 mutations in carcinomas of the esophagus, esophagogastric junction, and stomach.

  2023cites this paper
• The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification

  2023cites this paper
• Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?

  2023cites this paper
• The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target

  2023cites this paper
• A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.

  2023cites this paper
• Cytomorphologic features of SMARCA4‐deficient non–small cell lung carcinoma and correlation with immunohistochemical and molecular features

  2022cites this paper
• SMARCA4-associated malignant rhabdoid tumors: case report and literature review

  2022cites this paper
• Case report of bilateral ovarian fibromas associated with de novo germline variants in PTCH1 and SMARCA4

  2022cites this paper
• SWI/SNF‐deficient undifferentiated malignancies: where to draw the line†

  2021cites this paper
• Malignant brain tumor in an infant showing histopathological features of yolk sac tumor but genetic and epigenetic features of AT/RT

  2021cites this paper
• SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type

  2021cites this paper
• Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group

  2021cites this paper
• Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines

  2020cites this paper
• Rhabdoid Tumor, Soft Tissue

  2020cites this paper
• The variability of SMARCA4‐related Coffin–Siris syndrome: Do nonsense candidate variants add to milder phenotypes?

  2020cites this paper
• Small Cell Carcinoma of the Ovary, Hypercalcaemic Type – genetics, new treatment targets and current management guidelines

  2020cites this paper
• Coffin-Siris Syndrome 4-Related Spectrum in a Young Woman Caused by a Heterozygous SMARCA4 Deletion Detected by High-Resolution aCGH

  2020cites this paper
• A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer

  2020cites this paper
• Atypical teratoid/rhabdoid tumors of the central nervous system in children: the state of the problem today. Literature review

  2019cites this paper
• Management of Gynecologic Cancers In Relation to Genetic Predisposition.

  2019cites this paper
• Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities

  2019cites this paper
• SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association

  2019cites this paper
• An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings

  2019cites this paper
• Gynecological neoplasms associated with paraneoplastic hypercalcemia.

  2019cites this paper
• [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].

  2019cites this paper
• Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts

  2019cites this paper
• Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma

  2019cites this paper
• Infantile Pulmonary Teratoid Tumor.

  2018cites this paper
• Hereditary SWI/SNF complex deficiency syndromes.

  2018cites this paper
• BAFfling pathologies: Alterations of BAF complexes in cancer.

  2018cites this paper
• Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)

  2018cites this paper
• Ovarian small cell carcinoma in one of a pair of monozygous twins

  2018cites this paper
• Predisposition Syndromes to Central Nervous System Cancers

  2018cites this paper
• INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor

  2018cites this paper
• Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome

  2017cites this paper
• SMARCA4 inactivating mutations cause concomitant Coffin–Siris syndrome, microphthalmia and small‐cell carcinoma of the ovary hypercalcaemic type

  2017cites this paper
• Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.

  2017cites this paper
• Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.

  2017cites this paper
• The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases

  2016cites this paper
• Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations

  2016cites this paper
• Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

  2016cites this paper
• Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type

  2016cites this paper
• All things rhabdoid and SMARC: An enigmatic exploration with Dr. Louis P. Dehner.

  2016cites this paper
• SMARCA4‐Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression

  2016cites this paper
• Rhabdoid Tumor Predisposition Syndrome

  2015cites this paper
• SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

  2015cites this paper
• Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

  2015cites this paper
• Characterization of epithelioid sarcoma using massively parallel DNA and RNA sequencing and in vitro models

  2015cites this paper
• SWI/SNF chromatin remodeling and human malignancies.

  2015cites this paper
• Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type

  2015cites this paper
• Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

  2015cites this paper
• SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor): A Comprehensive Analysis of 116 Rare Gynecologic Tumors, 9 Soft Tissue Tumors, and 9 Melanomas

  2015cites this paper
• Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 patients.

  2015influential citation
• No small surprise – small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour

  2014influential citation
• Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma

  2014cites this paper
• SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis

  2014cites this paper
• SWI/SNF chromatin remodeling complexes and cancer

  2014cites this paper
• Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

  2014cites this paper
• Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.

  2014cites this paper
• Next‐generation sequencing: a change of paradigm in molecular diagnostic validation

  2014cites this paper
• Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

  2014cites this paper
• Atypical teratoid / rhabdoid tumors of the central nervous system in children : the state of the problem today

  year unknowncites this paper